Emvision Medical Devices Limited (ASX:EMV)
EMVision Medical Devices Limited (ASX:EMV) is focused on the development and commercialisation of medical imaging technology.
EMV is developing and seeking to commercialise a cost effective, portable, medical imaging device using electromagnetic microwave imaging for diagnosis and monitoring of stroke and other medical applications. The technology is the result of over 10 years of development by researchers at the University of Queensland.
The team of approximately 20 researchers is led by co-inventors Professor Amin Abbosh and Professor Stuart Crozier. EMVision CEO, Dr Ron Weinberger, is the former CEO of Nanosonics (ASX:NAN). During his time at Nanosonics, Dr Weinberger was instrumental in transforming Nanosonics from a research and development company to one of Australia’s leading medical device commercialisation success stories.